Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
In the latest session, Procept BioRobotics Corp (NASDAQ: PRCT) closed at $53.98 down -4.14% from its previous closing price of $56.31. In other words, the price has decreased by -$4.14 from its previous closing price. On the day, 0.94 million shares were traded. PRCT stock price reached its highest trading level at $55.88 during the session, while it also had its lowest trading level at $53.6.
Ratios:
For a deeper understanding of Procept BioRobotics Corp’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.75 and its Current Ratio is at 8.95. In the meantime, Its Debt-to-Equity ratio is 0.21 whereas as Long-Term Debt/Eq ratio is at 0.20.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Morgan Stanley on December 02, 2024, initiated with a Overweight rating and assigned the stock a target price of $105.
On November 14, 2024, Jefferies started tracking the stock assigning a Hold rating and target price of $95.
On August 11, 2023, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $42.Piper Sandler initiated its Overweight rating on August 11, 2023, with a $42 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 18 ’25 when Zadno Reza sold 5,475 shares for $57.06 per share. The transaction valued at 312,404 led to the insider holds 173,070 shares of the business.
Waters Kevin sold 733 shares of PRCT for $41,825 on Mar 18 ’25. The EVP, CFO now owns 107,991 shares after completing the transaction at $57.06 per share. On Mar 18 ’25, another insider, Shiblaq Hisham, who serves as the EVP, Chief Comm. Officer of the company, sold 247 shares for $57.06 each. As a result, the insider received 14,094 and left with 63,133 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRCT now has a Market Capitalization of 2959113472 and an Enterprise Value of 2730025728. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.88 while its Price-to-Book (P/B) ratio in mrq is 7.34. Its current Enterprise Value per Revenue stands at 10.959 whereas that against EBITDA is -29.986.
Stock Price History:
The Beta on a monthly basis for PRCT is 1.09, which has changed by -0.12568837 over the last 52 weeks, in comparison to a change of 0.09969199 over the same period for the S&P500. Over the past 52 weeks, PRCT has reached a high of $103.81, while it has fallen to a 52-week low of $47.04. The 50-Day Moving Average of the stock is -6.77%, while the 200-Day Moving Average is calculated to be -26.29%.
Shares Statistics:
For the past three months, PRCT has traded an average of 1.04M shares per day and 1442410 over the past ten days. A total of 54.82M shares are outstanding, with a floating share count of 51.88M. Insiders hold about 5.37% of the company’s shares, while institutions hold 89.68% stake in the company. Shares short for PRCT as of 1744675200 were 6072298 with a Short Ratio of 5.85, compared to 1741910400 on 5829532. Therefore, it implies a Short% of Shares Outstanding of 6072298 and a Short% of Float of 14.91.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
